Willner Paul
Dept. of Psychology, Swansea University, Swansea, SA2 8PP, UK.
Neurobiol Stress. 2016 Aug 24;6:78-93. doi: 10.1016/j.ynstr.2016.08.002. eCollection 2017 Feb.
Now 30 years old, the chronic mild stress (CMS) model of depression has been used in >1300 published studies, with a year-on-year increase rising to >200 papers in 2015. Data from a survey of users show that while a variety of names are in use (chronic mild/unpredictable/varied stress), these describe essentially the same procedure. This paper provides an update on the validity and reliability of the CMS model, and reviews recent data on the neurobiological basis of CMS effects and the mechanisms of antidepressant action: the volume of this research may be unique in providing a comprehensive account of antidepressant action within a single model. Also discussed is the use of CMS in drug discovery, with particular reference to hippocampal and extra-hippocampal targets. The high translational potential of the CMS model means that the neurobiological mechanisms described may be of particular relevance to human depression and mechanisms of clinical antidepressant action.
如今已有30年历史的慢性轻度应激(CMS)抑郁症模型已在超过1300篇已发表的研究中被使用,2015年同比增长至超过200篇论文。一项针对用户的调查数据显示,虽然使用了各种名称(慢性轻度/不可预测/多样应激),但这些基本上描述的是相同的程序。本文提供了关于CMS模型有效性和可靠性的最新信息,并综述了关于CMS效应的神经生物学基础和抗抑郁作用机制的最新数据:这项研究的规模可能独一无二,它在单一模型中全面阐述了抗抑郁作用。还讨论了CMS在药物发现中的应用,特别提及海马体和海马体外靶点。CMS模型的高转化潜力意味着所描述的神经生物学机制可能与人类抑郁症及临床抗抑郁作用机制特别相关。